Norethindrone And Ethinyl Estradiol And Ferrous Fumarate
Pricing Report NDC 68180-897-13

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

The latest wholesale acquisition cost for Norethindrone And Ethinyl Estradiol And Ferrous Fumarate (NDC 68180-897-13) is $2.30364 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 20, 2015.

As a provided by Lupin Pharmaceuticals, Inc., this medication is distributed in a 5 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$2.30364
Per EA

Effective Date
May 20, 2015
Billable Units
5 EA
Estimated Package Price
$11.52
Data Status
As of May 20, 2015
C/I - Chain or Independent Pharmacy
Package NDC
Description
5 POUCH in 1 CARTON / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $1.40178 to $2.45005 per EA. Over this 1 year and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$1.4018 - $2.4501
Market Volatility
74.78% Variance
Latest Trend
5.79%
Date Unit Price Unit Source Method Rate
May 20, 2015 $2.30364 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2015 $2.17752 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2015 $2.43936 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2015 $2.43936 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Nov 19, 2014 $2.45005 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2014 $2.45005 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Oct 22, 2014 $2.01639 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2014 $1.96241 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 20, 2014 $2.42399 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 23, 2014 $2.29010 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 18, 2014 $1.80473 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 21, 2014 $1.93759 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 23, 2014 $2.08851 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 19, 2014 $2.13456 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $1.76461 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2014 $1.76461 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Dec 18, 2013 $1.48835 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 24, 2013 $1.40178 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026